We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLS:ASXTelstra Group Limited Analysis

Data as of 2026-09-07 - not real-time

A$4.77

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Telstra Group Limited trades at AUD 4.77, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 3.2% over the past 30 days. Momentum indicators put RSI at 48.2 (neutral) with MACD reading bullish. Watch AUD 4.56 as support and AUD 5.01 as the nearer resistance level.
On valuation the read is overvalued — earnings multiple of 23.9 versus a 15.5 sector average, above the peer group. Analyst price targets sit 5.1% above the current price. Revenue is contracting at 2.0% on a 9.8% profit margin. The 4.38% dividend yield looks stretched against payout coverage.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 18.3%, a beta of -0.03 and a maximum drawdown of 17.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

There are good reasons why Telstra Group Ltd ASX: TLS and these ASX dividend shares are high on my passive income list.The Telstra Group Ltd ASX: TLS dividend has been announced, and it’s another big increase for shareholders…Are Telstra Group Ltd ASX: TLS shares a good buy for passive income?

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 5.05
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 23.9 versus sector average of 15.5
  • Dividend yield of 4.38% looks stretched against payout coverage

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 23.9 versus sector average of 15.5
  • Dividend yield of 4.38% looks stretched against payout coverage
  • Analyst targets imply +5.1% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-2.00%
Profit Margin9.77%
P/E Ratio23.9
ROE15.37%
ROA5.90%
Debt/Equity126.28
P/B Ratio4.2
Op. Cash FlowA$7.6B
Free Cash FlowA$3.4B
Industry P/E15.5

Technical Analysis

TrendBearish
RSI48.2
SupportA$4.56
ResistanceA$5.01
MA 20A$4.74
MA 50A$4.89
MA 200A$5.05
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair ValueA$2.31
Target PriceA$5.01
Upside/Downside5.07%
GradeOvervalued
TypeBlend
Dividend Yield4.38%

Risk Assessment

Beta-0.03
Volatility18.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.